Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126708581 | 12670858 | 1 | I | 20140606 | 0 | 20160819 | 20160819 | DIR | 18.00 | YR | F | N | 190.00000 | LBS | 20151025 | Y | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126708581 | 12670858 | 1 | PS | HEPARIN | HEPARIN SODIUM | 1 | 10,000UNITS IN 500MLNS 3/EAY WEK/3HR.EH RIJ TUNNELED CATHETER | N | D | 0 | |||||||||
| 126708581 | 12670858 | 3 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 4 | SS | RAPAMUNE | SIROLIMUS | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 5 | SS | TACROLIMUS. | TACROLIMUS | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 6 | SS | ALEMTUZUMAB | ALEMTUZUMAB | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 7 | SS | VALCYTE | VALGANCICLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 10 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 12 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 14 | C | GRAFAMUNE | 2 | 0 | |||||||||||||
| 126708581 | 12670858 | 16 | C | TARCO | 2 | 0 | |||||||||||||
| 126708581 | 12670858 | 18 | C | VORICONAZOLE. | VORICONAZOLE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 20 | C | CASPOFUNGIN | CASPOFUNGIN | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 22 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 24 | C | AMOLDIPINE BESYLATE 5MG LEGACY PHARMACEUTICAL | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 26 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 28 | C | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 30 | C | VALGANCICLOVIR-HYDROCHLORIDE | 2 | 0 | |||||||||||||
| 126708581 | 12670858 | 32 | C | TAB-A-VITE | 2 | 0 | |||||||||||||
| 126708581 | 12670858 | 34 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 36 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 38 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126708581 | 12670858 | 40 | C | CATARPRES TTS-1 | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126708581 | 12670858 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126708581 | 12670858 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126708581 | 12670858 | Aspergillus infection | |
| 126708581 | 12670858 | Klebsiella infection | |
| 126708581 | 12670858 | Liver injury | |
| 126708581 | 12670858 | Overdose | |
| 126708581 | 12670858 | Pathogen resistance | |
| 126708581 | 12670858 | Renal failure | |
| 126708581 | 12670858 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126708581 | 12670858 | 1 | 20140506 | 20150624 | 0 |